Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 15,317 | 15,884 | 19,570 | 27,430 | 33,744 |
| Operating Income | -15,317 | -15,884 | -19,570 | -27,430 | -33,744 |
| Interest Expense | 619 | 48 | 0 | 49 | 69 |
| Other Income | -11,021 | 1,016 | 1,340 | 775 | -125 |
| Pre-tax Income | -26,957 | -14,916 | -18,231 | -26,704 | -33,938 |
| Net Income Continuous | -26,957 | -14,916 | -18,231 | -26,704 | -33,938 |
| Net Income Discontinuous | N/A | 0 | 0 | 3,097 | -1,347 |
| Minority Interests | 782 | 713 | 328 | N/A | N/A |
| Net Income | $-26,175 | $-14,203 | $-17,902 | $-23,607 | $-35,285 |
| EPS Basic Total Ops | -8.20 | -13.12 | -29.90 | -39.65 | -65.65 |
| EPS Basic Continuous Ops | -8.20 | -13.12 | -29.90 | -44.85 | -63.05 |
| EPS Basic Discontinuous Ops | N/A | 0.00 | 0.00 | 5.20 | -2.60 |
| EPS Diluted Total Ops | -8.20 | -13.12 | -29.90 | -39.65 | -65.65 |
| EPS Diluted Continuous Ops | -8.20 | -13.12 | -29.90 | -44.85 | -63.05 |
| EPS Diluted Discontinuous Ops | N/A | 0.00 | 0.00 | 5.20 | -2.60 |
| EBITDA(a) | $-25,792 | $-14,377 | $-15,724 | $-22,117 | $-29,823 |